Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuma Oyama

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Heart Journal|September 19, 2021
Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trialKazuma Oyama, Robert P Giugliano, Minao Tang, et al.
European Heart Journal|March 24, 2021
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trialKazuma Oyama, Robert P Giugliano, David D Berg, et al.
Journal of the American College of Cardiology|November 16, 2020
Effect of Evolocumab on Complex Coronary Disease Requiring RevascularizationKazuma Oyama, Remo H M Furtado, Antonio Fagundes, et al.
International Journal of Cardiology. Heart & Vasculature|February 2, 2026
Cancer history and mortality risk in acute myocardial infarction: Insights from the Japan AMI registryAyumi Adachi, Kazuma Oyama, Jun Takahashi, et al.
JAMA Cardiology|July 20, 2022
Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical TrialKazuma Oyama, Itamar Raz, Avivit Cahn, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 7, 2015
Accuracy of optical frequency domain imaging for evaluation of coronary adventitial vasa vasorum formation after stent implantation in pigs and humans - a validation study - Kensuke Nishimiya, Yasuharu Matsumoto, Hironori Uzuka, et al.
Circulation. Cardiovascular Interventions|February 25, 2022
Effect of Evolocumab in Patients With Prior Percutaneous Coronary InterventionRemo H M Furtado, Antônio Aurélio Fagundes, Kazuma Oyama, et al.
Journal of the American College of Cardiology|August 25, 2022
Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER TrialAntonio Fagundes, David A Morrow, Kazuma Oyama, et al.
The American Journal of Cardiology|October 26, 2013
Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery diseaseYoichi Imori, Takeshi Akasaka, Tomoki Ochiai, et al.
Journal of Atherosclerosis and Thrombosis|December 21, 2025
Lipid Management for Secondary Prevention in Atherosclerotic Cardiovascular Disease: A Scoping Review and Scientific ReportAtsushi Tanaka, Kazuma Oyama, Yusuke Yakushiji, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Heart Journal|September 19, 2021
Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trialKazuma Oyama, Robert P Giugliano, Minao Tang, et al.
European Heart Journal|March 24, 2021
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trialKazuma Oyama, Robert P Giugliano, David D Berg, et al.
Journal of the American College of Cardiology|November 16, 2020
Effect of Evolocumab on Complex Coronary Disease Requiring RevascularizationKazuma Oyama, Remo H M Furtado, Antonio Fagundes, et al.
International Journal of Cardiology. Heart & Vasculature|February 2, 2026
Cancer history and mortality risk in acute myocardial infarction: Insights from the Japan AMI registryAyumi Adachi, Kazuma Oyama, Jun Takahashi, et al.
JAMA Cardiology|July 20, 2022
Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical TrialKazuma Oyama, Itamar Raz, Avivit Cahn, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 7, 2015
Accuracy of optical frequency domain imaging for evaluation of coronary adventitial vasa vasorum formation after stent implantation in pigs and humans - a validation study - Kensuke Nishimiya, Yasuharu Matsumoto, Hironori Uzuka, et al.
Circulation. Cardiovascular Interventions|February 25, 2022
Effect of Evolocumab in Patients With Prior Percutaneous Coronary InterventionRemo H M Furtado, Antônio Aurélio Fagundes, Kazuma Oyama, et al.
Journal of the American College of Cardiology|August 25, 2022
Biomarker Prediction of Complex Coronary Revascularization Procedures in the FOURIER TrialAntonio Fagundes, David A Morrow, Kazuma Oyama, et al.
The American Journal of Cardiology|October 26, 2013
Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery diseaseYoichi Imori, Takeshi Akasaka, Tomoki Ochiai, et al.
Journal of Atherosclerosis and Thrombosis|December 21, 2025
Lipid Management for Secondary Prevention in Atherosclerotic Cardiovascular Disease: A Scoping Review and Scientific ReportAtsushi Tanaka, Kazuma Oyama, Yusuke Yakushiji, et al.
Pageof 3